ProAssurance (PRA)
(Delayed Data from NYSE)
$13.39 USD
+0.22 (1.67%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $13.38 -0.01 (-0.07%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.39 USD
+0.22 (1.67%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $13.38 -0.01 (-0.07%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum D VGM
Zacks News
MarketAxess' (MKTX) Q1 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
MarketAxess' (MKTX) Q1 earnings reflect better trading volumes and decent revenue stream. It witnessed record U.S. Treasury, emerging markets and municipal bond revenues.
5 Insurers Set to Outshine Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help PRA, VOYA, HMN, AJG, and AFL outperform Q1 earnings estimates.
Can Rising Costs Play Spoilsport for AmEx (AXP) Q1 Earnings?
by Zacks Equity Research
American Express' (AXP) first-quarter results are likely to reflect increased net interest income amid the growing global commercial services expenses.
Synchrony Financial (SYF) Q1 Earnings Beat on Purchase Volume
by Zacks Equity Research
Synchrony Financial (SYF) currently has a share buyback authorization of $3.1 billion, thanks to the approval of a new $2.8-billion repurchase program.
5 Insurers Poised to Beat Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help PRA, VOYA, HIG, BRO, and AFL outperform Q1 earnings estimates.
What to Expect From Synchrony Financial's (SYF) Q1 Earnings
by Zacks Equity Research
Synchrony Financial's (SYF) first-quarter results are likely to reflect increased marketing and business development costs.
Why Is ProAssurance (PRA) Up 4.4% Since Last Earnings Report?
by Zacks Equity Research
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Hold ProAssurance (PRA) in Your Portfolio?
by Zacks Equity Research
Banking on strategic growth initiatives and an improving top line, ProAssurance (PRA) holds the potential to reap benefits for investors.
ProAssurance (PRA) Q4 Earnings Beat on High Premiums, Up Y/Y
by Zacks Equity Research
ProAssurance's (PRA) fourth-quarter 2021 results are aided by the NORCAL acquisition.
ProAssurance (PRA) to Post Q4 Earnings: What You Need to Know
by Zacks Equity Research
ProAssurance's (PRA) fourth-quarter results are likely to reflect increased net investment income and premiums earned.
ProAssurance (PRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
ProAssurance (PRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Stay Invested in Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given a change in the attitude of pet owners, who are increasingly focusing on pets' health and well-being.
Arch Capital (ACGL) Up 39% in a Year: More Room for Growth?
by Zacks Equity Research
New business opportunities, rate increases, growth in existing accounts, and solid capital position continue to drive Arch Capital (ACGL).
Travelers (TRV) Benefits From Solid Segmental Performance
by Zacks Equity Research
Travelers (TRV) remains poised to benefit from strong retention, new business, improved pricing and prudent capital deployment.
Cincinnati Financial (CINF) Up 29% in a Year: More Upside Left?
by Zacks Equity Research
Agent-centered business model, improving premium, industry-leading margins, and solid capital position continue to drive Cincinnati Financial (CINF).
Here's Why Hold Strategy is Apt for Chubb Limited (CB) Stock
by Zacks Equity Research
New business growth, strong renewal retention and effective capital deployment continue to drive Chubb Limited (CB).
Should You Retain Axis Capital (AXS) Stock in Your Portfolio?
by Zacks Equity Research
AXIS Capital (AXS) is poised to benefit from positive returns from alternative assets, new business growth and prudent capital deployment.
4 P&C Insurers Poised to Continue Their Winning Streak in 2022
by Zacks Equity Research
Backed by improved pricing, technology advancements and global expansion, stocks in the property and casualty insurance industry like SIGI, FAF, BRK.B, PRA are likely to gain in 2022.
ProAssurance (PRA) Up 31.5% in A Year: More Growth Ahead?
by Zacks Equity Research
ProAssurance's (PRA) cost-control initiatives are likely to lower costs to a great extent and boost the bottom line.
American International (AIG) Opts for AWS to Boost Efficiency
by Zacks Equity Research
American International's (AIG) move of selecting AWS is expected to support its AIG 200 strategy.
The Zacks Analyst Blog Highlights: Athene Holdings, ProAssurance Corp and Fidelity National Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Athene Holdings, ProAssurance Corp and Fidelity National Financial
3 Insurance Stocks That Have Outperformed S&P 500 YTD
by Tanuka De
Insurers Athene (ATH), ProAssurance (PRA) and Fidelity National (FNF) have outperformed the industry, the sector and the S&P 500 composite year to date and are poised to retain the rally given solid prospects.
Why Should You Add ProAssurance (PRA) to Your Portfolio?
by Zacks Equity Research
Riding on inorganic growth and cost-curbing measures, ProAssurance (PRA) holds the potential to reap benefits for investors.
Allstate (ALL) on Track to Sell Property to Reduce Expenses
by Zacks Equity Research
Allstate (ALL) to divest part of its Northbrook, IL property to warehouse builder Dermody Properties to cut down on expenses.
Why Should You Hold Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on inorganic growth measures and disciplined capital management, Marsh & McLennan (MMC) holds enough potential to reap benefits to investors.